BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16580546)

  • 1. Serum plant sterols and atherosclerosis: is there a place for statin-ezetimibe combination?
    Radermecker RP; Scheen AJ
    J Am Coll Cardiol; 2006 Apr; 47(7):1496-7; author reply 1497-8. PubMed ID: 16580546
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patients.
    Naruse R; Hori K; Terasawa T; Hara K; Suetsugu M; Takebayashi K; Morita K; Aso Y; Inukai T
    Obes Res Clin Pract; 2015; 9(1):67-74. PubMed ID: 25660177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niacin compared with ezetimibe.
    Roman MJ
    N Engl J Med; 2010 Mar; 362(11):1047-8; author reply 1048. PubMed ID: 20301796
    [No Abstract]   [Full Text] [Related]  

  • 6. Niacin compared with ezetimibe.
    Duivenvoorden R; Vergeer M; Kastelein JJ
    N Engl J Med; 2010 Mar; 362(11):1046-7; author reply 1048. PubMed ID: 20301795
    [No Abstract]   [Full Text] [Related]  

  • 7. Niacin compared with ezetimibe.
    Lindsay AC; Halcox JP
    N Engl J Med; 2010 Mar; 362(11):1046; author reply 1048. PubMed ID: 20237352
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins targeting inflammation by lowering low-density lipoprotein?
    Tuzcu EM; Nicholls SJ
    J Am Coll Cardiol; 2007 May; 49(20):2010-2. PubMed ID: 17512356
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
    Robinson JG; Davidson MH
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
    Athyros VG; Tziomalos K; Kakafika AI; Koumaras H; Karagiannis A; Mikhailidis DP
    Am J Cardiol; 2008 Feb; 101(4):483-5. PubMed ID: 18312762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol absorption inhibitors: a closer look.
    Lehmann R; Ramsey LA
    Adv Nurse Pract; 2003 Nov; 11(11):28-31. PubMed ID: 14639879
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination therapy of hypercholesterolemia].
    Vanhanen H; Gylling H; Miettinen TA
    Duodecim; 2002; 118(19):1967-73. PubMed ID: 12462803
    [No Abstract]   [Full Text] [Related]  

  • 17. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 18. The discovery of ezetimibe: a view from outside the receptor.
    Clader JW
    J Med Chem; 2004 Jan; 47(1):1-9. PubMed ID: 14695813
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.
    Fichtlscherer S; Schmidt-Lucke C; Bojunga S; Rössig L; Heeschen C; Dimmeler S; Zeiher AM
    Eur Heart J; 2006 May; 27(10):1182-90. PubMed ID: 16621868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin + ezetimibe: a combination with no proven advantages.
    Prescrire Int; 2007 Apr; 16(88):67. PubMed ID: 17460829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.